NCT04347434View on ClinicalTrials.gov

Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI

PHASE4RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 12, 2020

Primary Completion Date

November 12, 2027

Study Completion Date

December 30, 2027

Conditions
Myocardial Infarction, AcuteMyocardial StrainArterial StiffnessQuality of Life
Interventions
DRUG

Atorvastatin 80mg

Atorvastatin is prescribed at a dose of 80 mg / day from the first 24-96 hours of AMI in addition to the standard therapy

Trial Locations (1)

440026

RECRUITING

Valentin Oleynikov, Penza

All Listed Sponsors
lead

Penza State University

OTHER